Azithromycin associated with higher remission rate among patients with chronic Asthma: Study
Azithromycin is associated with a higher remission rate among patients with chronic Asthma suggests a study published in the Chest. This secondary analysis used data from the AMAZES clinical trial – a double-blind placebo-controlled trial that evaluated the safety and efficacy of azithromycin on asthma exacerbations. The primary remission definition (referred to as clinical remission) […]